Regulatory Considerations For Process Intensification

What are the regulatory considerations for implementing process intensification? In this segment of the BioProcess Online Live! event “Upstream Process Intensification In Practice,” Sonnet Buotherapeutics CTO Susan Dexter and process intensification pioneer Parrish Galliher cover the fundamental aspects of the FDA’s expectations around minor and major change reporting and process validation.